News Home

Is Incyte Corporation (INCY) a Smart Choice in Biotechnology Friday?

Friday, December 01, 2023 03:36 PM | InvestorsObserver Analysts

Mentioned in this article

Is Incyte Corporation (INCY) a Smart Choice in Biotechnology Friday?

A rating of 47 puts Incyte Corporation (INCY) near the middle of the Biotechnology industry according to InvestorsObserver. Incyte Corporation's score of 47 means it scores higher than 47% of stocks in the industry. Incyte Corporation also received an overall rating of 43, putting it above 43% of all stocks. Biotechnology is ranked 46 out of the 148 industries.

Overall Score - 43
INCY has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on INCY!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Incyte Corporation Stock Today?

Incyte Corporation (INCY) stock is down -1.14% while the S&P 500 has gained 0.57% as of 3:33 PM on Friday, Dec 1. INCY is down -$0.62 from the previous closing price of $54.34 on volume of 970,124 shares. Over the past year the S&P 500 has gained 12.69% while INCY is down -33.42%. INCY earned $1.88 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 28.54. Click Here to get the full Stock Report for Incyte Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App